• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,370.81 -161.78
(-0.31%)
Dow Jones
7,725.73 -1.30
(-0.02%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.73 0.08
(0.09%)
EUR-INR
109.20 -0.36
(-0.33%)
GBP-INR
127.12 -0.62
(-0.48%)
JPY-INR
0.61 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
535341
INE04LG01015
91.0101168
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PAR
11.15
161.57
EPS(TTM)
Face Value()
Div & Yield %
11.78
10
0
 

Monolithisch India consolidated net profit rises 80.62% in the March 2026 quarter
May 04,2026
Net profit of Monolithisch India rose 80.62% to Rs 8.11 crore in the quarter ended March 2026 as against Rs 4.49 crore during the previous quarter ended March 2025. Sales rose 34.87% to Rs 40.65 crore in the quarter ended March 2026 as against Rs 30.14 crore during the previous quarter ended March 2025.

For the full year,net profit rose 60.38% to Rs 23.03 crore in the year ended March 2026 as against Rs 14.36 crore during the previous year ended March 2025. Sales rose 38.99% to Rs 135.29 crore in the year ended March 2026 as against Rs 97.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales40.6530.14 35 135.2997.34 39
OPM %28.0921.70 -23.6221.66 -
PBDT11.676.44 81 33.2620.78 60
PBT10.936.01 82 30.8819.27 60
NP8.114.49 81 23.0314.36 60